Anthem Biosciences Limited · NSE:ANTHEM
Anthem Biosciences — Q1 FY2026 Earnings Presentation
10 slides from Anthem Biosciences's earnings presentation, Aug 13, 2025
Slide 1: Earnings Call Presentation Q1 FY 2025-26 filing letter
/\nthem:? BioSciences To, BSE Limited, 20th Floor, P.J. Towers, Dalal Street, Mumbai - 400001. BSE Scrip Code: 544449 Anthem Biosciences Limited (Formerly known as Anthem Biosciences Pvt. Ltd.) 49, Fl & F2, Canara Bank Road, Bommasandra Industrial Area, Phase - I Bommasandra, Bengaluru - 560 099 Kar
Slide 2: Anthem Biosciences Limited Investor Presentation, August 13, 2025
G7Z0z ‘E} ysnsny UOL}LJUISAJg JO}SSAU| Pa}LWI] S9DUaLDSOIg WaUUY SaduUa!ISO!
Slide 3: Safe Harbour
sadualrsoig TWUSUTUYS *JO9J9Y} o}ep ay} Jaye sadueSWINIILD JO SJUGAA }Da9]Ja1 0} s}UBWA}e}s SULyOO]-psemioj ajzepdn 0} uoNesiygo Aue ayeyapun jou saop Auedwos ay “sys J9Y4}O-Se ]}9M Se S¥SLI JaYIeW 0} aunsodxa uno ‘suol}Dafo1d Mo}j Ysed ‘@WODUL Ss@UIsNg puke JUSWS2AUL ‘sasuey> -]e2180}0UYIa} ‘saLdI]
Slide 4: Consolidated Profit & Loss Statement
sa 2ualzsol els‘y %bb9 978 %8'P9 v78 gce‘L XB} 19732 WyOld 9S60‘7 %E LY 156 4B Lb 9GE GOS asuadxa xe} }e]0) 6959 2S’ €8Z‘b %6°LS ost ‘h 798‘L XB} 910jaq HJOld v68 BL EL- vOE %9' LE Z81 y9TZ asuadxa uolzezljowe pue uoljzelda1daq fOL %0°607 G %S°9S- LE 9L jsoD adueuly eo 6E %0'b- hier Sb b- eo 6E BV B
Slide 5: Q1 FY26 Consolidated Financial Highlights
sa 2ualzsol (aBe%) suissew Ivd pue (UW 2) Lvd (aBe%) suissew valida pue (UW >) VaLIaa S}YB1]YBIH JeIDUeULY payeplosuoD 9ZAILO SZ0z ‘o€ eunr SZOz ‘LE Jew 9ZAALO SZASLO ; %8°E8 ‘ owau> z98't oer aids enusrsy 9TAALO 5 amt %6'TE %HL9L we9 squarpoiBuy gre‘ Aypiredg (uw =) Yyse> JON (aBe%) sulssew Lad pue
Slide 6: Strong financial performance with robust CRDMO pipeline for FY26
«| sa2ual iso! 9ZAJID Ul pauolssiWWOd |] [UN Je UOIsUedXAa Ty OE A42 JO INO TPS :AI0N, VGLIGA 9ZASLO / YSeD JON XLO'L IN JBAOUINL SASSY PAXL4 SSOID OZAAID XH9'L ADON XL 380d YZAALD / JOU %C'8T / %8' LT Aqoedes uoljyeUaW34 ACH h IN Ayioedes sisayquAs wosn> LIAVCE 3923S DyUAalDS / saako|dwy # GrO‘'l /
Slide 7: Q1 FY26 Financial Highlights
sa 2ualzsol UW 88‘Zz SI ‘GZOZ ‘OE auNr Jo se UOlzSOd YyseD J9N = %vT ye SULBIEW 1d YUM “UW BGE‘}> SeM (Xe] JaIV WJOld) 1Vd = %RE Fe suLsIeW YOLIGa YUM “UW EFL ‘Zz SEM VGLIGS = Sanuadal UW G/8z PAJ9Alap s}uaLpassu] Ayeivads =a sanuaral UW 7G ‘Pz PaJaAl|ap sseuisngq OWGUD = 4azzenb ay} 10} UW ZOP‘G> S
Slide 8: Business Highlights
sa 2ualzsol | Va asojesueg ‘iyjeyosey 3e SPs a19e OE BY} 3e AqIDeJ pjaljusess Mau e J0J AeMJapUN UO!}INAYSUOD PUe pUuNOJS ayolg = <(yyeyoseH) ALHUN = (Aytzede> 74¢°Z) Ayyioes SuLinyoeynuew yUa}0d-1y a]eds yelDaWIWOD pue (Ajloede> 7491) Aqpoey SuLinjoeynuew apijded ayers jelosaWWOD pazedipap ‘j1e-3yj
Slide 9: Message from Chairman and MD, Ganesh Sambasivam
sa 2ualzsol 04) B GW ‘ueweYy> CVMGYVHE AVIV +, SSaulsng s}Uualpassuy AeLdads pue QWGYD Y}0q ssojde adUeWOJJad JaAWap sn padjay sey sdiyssouzed jUaL)d Sulpuejs-suo] pue aduUa}]}a9Xa JeUuolJeJado ‘snd0j dISa}eI}s ‘Weda} pazedIpap e JO UOLJEULQUIOD Y “GZA4ZO 22UIs dn Suldwes paziejs Jey} Weas}s aNUdAaI
Slide 10: Investor contact details
WO0D*1dsj0}DeJPE@Way}Ue JO WOD*O1QUIaYJU®)]qe *SJO}SSAUL yoe}U0D aseajd UOLJOWUIOJUL J9YVINS JO4 eIpul ‘ZL LZ9G EyeJEUIeY “I}EYOuRH ‘qoujsiq weseuweY ‘yN]eL eindeyeuey ‘ase)}LA addnyiuueg sean “) aseyd ‘eauy yeLysnpu| lyyeyosey “OZ-ON AdAins ‘d-Z/7 B d-9ZZ ON 301d 211 UN eIpU ‘ZL LZ9G ‘eyeTeUey “INe